« Previous
Next »
The Journal of Urology
Volume 172, Issue 5,
Supplement
, Pages S38-S41
, November 2004
OPTIMIZING HORMONE THERAPY IN LOCALIZED PROSTATE CANCER: FOCUS ON EXTERNAL BEAM RADIOTHERAPY
REFERENCES
- . Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy . Int J Radiat Oncol Biol Phys . 2003;57:384
- Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial . Int J Radiat Oncol Biol Phys . 2002;53:1097
- Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer . J Clin Oncol . 2002;20:557
-
.
LH-RH analogue treatment for advanced prostate cancer
.
Am J Clin Oncol
. 1988;2(suppl):S120
- . Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system . Int J Radiat Oncol Biol Phys . 1997;38:1067
- . Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects . J Urol . 2001;166:500
- . Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy . Urology . 1997;49(suppl):38
- Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate . Int J Radiat Oncol Biol Phys . 2001;50:1243
- . Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 . J Clin Oncol . 2003;21:1904
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial . Lancet . 2002;360:103
- Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. long-term results of phase III RTOG study 85-31 . Int J Radiat Oncol Biol Phys . 2003;57(suppl):S172
- Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02 . J Clin Oncol . 2003;21:3972
- Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer . JAMA . 2000;284:1280
- Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy . J Urol . 2003;170:791
- Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: 3 year PSA recurrence rates . J Urol . 2003;169:179
PII: S0022-5347(05)61306-7
doi: 10.1097/01.ju.0000141682.27320.c6
© 2004 American Urological Association, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 172, Issue 5,
Supplement
, Pages S38-S41
, November 2004

